🔎 Trials Near Me

Home › Type 1 Diabetes › NCT05317455

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

RecruitingEarly phase 1

Who can join

Ages 18 to 55 · All sexes

Full eligibility criteria
Inclusion Criteria:

T1DM subjects with:

* a history of severe hypoglycemia and/or hypoglycemia unawareness or
* a history of severe hypoglycemia with a blood glucose \<54 mg/dL, requiring the assistance of another person (with recovery after the administration of oral carbohydrate, intravenous glucose, or glucagon) or
* at least 2 values \<54mg/dl during 2 weeks of CGMS testing during the week prior to study.

Exclusion Criteria:

* Age \< 18 years or \>55 years.
* Body weight \>85 kg at screening visit
* BMI \> 30 (female) and \>30 (male) kg/m2.
* Untreated proliferative retinopathy
* carriers of glutathione transferase Z1 (GSTZ-1) gene polymorphisms that predispose to DCA accumulation and toxicity

About the study

This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect of dichloroacetate on brain function under clamped hypoglycemia in T1DM.

What is being tested

Sponsor: Yale University · Participants: 16 · Started: May 13, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT05317455

Locations in the U.S.

ConnecticutYale-New Haven Hospital, New Haven

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.